Publications by authors named "Jacky Woo"

Claim this Profile
E
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial.
John Belperio, Tuan Nguyen, David A Lombardi, Maxim Bogus, Valentyn Moskalenko, Jacky Woo

BMJ Open Respir Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of JAK1-Preferential Inhibitor Filgotinib on Circulating Biomarkers and Whole Blood Genes/Pathways of Patients With Moderately to Severely Active Crohn's Disease.
Xavier Roblin, Adrian Serone, Oh Kyu Yoon, Luting Zhuo, Ethan Grant, Jacky Woo

Inflamm Bowel Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics and pharmacodynamics of selgantolimod, an oral Toll-like receptor 8 agonist: a Phase Ia study in healthy subjects.
Maribel Reyes, Justin D Lutz, Audrey H Lau, Anuj Gaggar, Ethan P Grant, Jacky Woo

Antivir Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19.
Dave Singh, Maxim Bogus, Valentyn Moskalenko, Robert Lord, Edmund J Moran, Jacky Woo, Ashley Woodcock

Eur Respir J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Gut-Selective Pan-Janus Kinase Inhibitor TD-1473 for Ulcerative Colitis: A Translational Medicine Programme.
William J Sandborn, Deanna D Nguyen, David T Beattie, Patrick Brassil, Whitney Krey, Jacky Woo

J Crohns Colitis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Carolina Boni, Harry L A Janssen, Marzia Rossi, Seung Kew Yoon, Andrea Vecchi, Jacky Woo

Gastroenterology· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B.
Harry L A Janssen, Maurizia R Brunetto, Yoon Jun Kim, Carlo Ferrari, Benedetta Massetto, Jacky Woo

J Hepatol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis.
Jacky Woo, Michel P M Vierboom, Hakju Kwon, Debra Chao, Shiming Ye

Arthritis Res Ther· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuation of aortic graft arteriosclerosis by systemic administration of Allotrap peptide RDP58.
Wei Li, Suhasini Iyer, Lina Lu, Roland Buelow, John J Fung, Jacky Woo

Transpl Int· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis